Cognitive Testing and Memory Assessment: What to Expect

Intro

When memory or thinking problems become a concern — whether noticed by the person themselves, a partner, or a family member — the natural next question is: what should happen now, and what will a doctor actually do?

Cognitive assessment is not a single test. It is a structured process that combines a detailed clinical history, standardised cognitive tools, and a search for underlying or contributing causes. Its goals are to establish whether there is a genuine problem, understand what is driving it, identify anything treatable, and — where appropriate — support planning for the future.

This guide explains what to expect at each stage, what the common tests involve, and what results can and cannot tell you.

Key Points

Cognitive assessment is a clinical process — not a pass/fail exam — that combines history, cognitive testing, blood tests, and sometimes imaging
Short screening tests (MMSE, MoCA, ACE-III) are useful starting points but are not diagnoses; they inform — they do not conclude
Reversible causes of cognitive symptoms — depression, thyroid disease, B12 deficiency, medication effects, sleep disorders — are always looked for first
A normal screening score does not rule out early problems, particularly in highly educated individuals or those with high baseline ability
Input from a family member or regular carer is an essential part of the assessment — the clinician needs to know what the person was like before
Sudden confusion, stroke symptoms, or rapid deterioration are not memory-clinic problems — they require urgent or emergency medical assessment

When Cognitive Testing Is Used

Cognitive assessment is initiated in a range of situations:

Concern from the person themselves Many people seek assessment after noticing changes in their own memory or thinking — words harder to find, difficulty keeping track of conversations, getting muddled in tasks that used to be automatic. Self-referral is appropriate and should not be delayed.

Concern from family or carers Family members often notice changes before the person does. Repeating questions, misplacing items in unusual places, withdrawing from activities, or subtle personality changes are patterns that family members are well placed to observe. A family member can speak to a GP about concerns even if the person is reluctant to seek help.

Functional changes Difficulties managing finances, medications, appointments, or cooking — especially when these were previously handled competently — can prompt assessment. Incidents such as getting lost in familiar areas or being involved in road accidents may also trigger referral.

After a delirium episode Delirium can unmask or accelerate underlying cognitive decline. Cognitive testing performed during or shortly after delirium is unreliable; a reassessment 4–6 weeks after recovery establishes a more accurate baseline. See: Delirium vs Dementia: How to Tell the Difference

Monitoring known mild cognitive impairment or early dementia People with an existing diagnosis of mild cognitive impairment (MCI) or early dementia will typically have cognitive testing repeated every 6–12 months to track stability or progression.

After stroke or TIA Post-stroke cognitive assessment is standard practice. Both stroke and transient ischaemic attacks can cause cognitive changes through direct brain injury or as a marker of underlying vascular disease.

What Happens at a First Assessment

A first assessment — usually with a GP — typically covers several distinct areas.

Clinical history

The clinician will ask:

What has changed, and when did it start?
Did it come on gradually or suddenly?
Which areas are most affected — memory, word-finding, planning, getting lost?
Is it getting worse, staying the same, or variable?
Has it affected work, driving, finances, or daily activities?

Collateral history

Input from someone who knows the person well — a partner, adult child, or close friend — is one of the most valuable parts of the assessment. They can describe changes the person may not be aware of, provide a sense of pace and severity, and flag concerns the person might downplay.

If a family member cannot attend in person, a phone call or written summary beforehand can be equally useful.

Medication review

Many commonly prescribed medications can impair memory, attention, and processing speed. The clinician will review the full medication list with specific attention to:

Anticholinergic drugs (some bladder medications, antihistamines, certain antidepressants)
Sedatives, sleeping tablets, and benzodiazepines
Opioid analgesics
Some blood pressure medications
Corticosteroids

Stopping or switching a contributory medication can produce meaningful cognitive improvement.

Mood and sleep review

Depression can produce cognitive slowing, poor concentration, and memory difficulties that closely mimic early dementia. Anxiety impairs working memory and attention. Untreated sleep apnoea fragments restorative sleep and consistently impairs cognition. These are assessed because treating them can substantially — and sometimes completely — reverse cognitive symptoms.

Functional and safety questions

How independently is the person managing? Can they handle their own medications, finances, cooking, and transport? Are there safety concerns — driving incidents, leaving the hob on, getting lost?

These functional questions are central to distinguishing normal aging and MCI from dementia, where daily independence is significantly impaired.

Common Cognitive Tests

Cognitive screening tools are standardised, scored assessments that map performance across multiple domains: memory, attention, language, executive function (planning and problem-solving), and visuospatial ability. They take 10–20 minutes and can be administered by a GP, nurse, or specialist.

They are clinical tools — not intelligence tests, and not pass/fail exams. Performance is always interpreted in context: age, education, anxiety on the day, fatigue, and physical health all affect scores.

MMSE — Mini-Mental State Examination

The MMSE is the most widely used screening tool worldwide. It covers:

Orientation to time and place (10 points)
Registration and recall of three words (6 points)
Attention and calculation (5 points)
Language tasks — naming, following instructions, writing (8 points)
Visuospatial — copying a simple figure (1 point)

Total: 30 points. Scores of 24 or above are generally considered within the normal range, though this threshold is not absolute. The MMSE is well established but has a significant limitation: it is relatively insensitive to mild cognitive impairment. A person with genuine early cognitive decline — particularly one with high baseline education — may score in the normal range.

MoCA — Montreal Cognitive Assessment

The MoCA was designed specifically to be more sensitive than the MMSE, particularly for detecting MCI. It assesses more domains and includes more demanding tasks:

Visuospatial and executive function (clock drawing, trail-making)
Naming three animals
Attention, serial subtraction
Sentence repetition and verbal fluency
Abstract reasoning
Delayed recall of five words
Orientation

Total: 30 points. A score of 26 or above is generally considered normal; one point is added for individuals with 12 or fewer years of formal education. The MoCA takes approximately 10–15 minutes and is the preferred screening tool in many memory clinics.

ACE-III — Addenbrooke’s Cognitive Examination III

The ACE-III is a more detailed assessment covering five domains: attention and orientation, memory, fluency (verbal and categorical), language, and visuospatial ability.

Total: 100 points. It takes 15–20 minutes and is more commonly used in specialist settings. Its greater sensitivity makes it useful for detecting subtle cognitive changes and for profiling which domains are most affected — which can help distinguish between different underlying conditions.

What these tests cannot do

They cannot diagnose dementia on their own — a clinical diagnosis requires the full picture
They cannot reliably identify who will progress from MCI to dementia
A single normal result does not exclude early or subtle impairment
They are affected by anxiety, fatigue, hearing or vision problems, and the testing environment
Performance varies with education, language, and cultural background

A note on results: If you or your family member scored in the normal range but concerns remain, say so. A clinician who understands the limitations of screening should take persistent, worsening symptoms seriously — even with a reassuring score. If concerns continue, ask about repeat testing in 6–12 months, or referral for more detailed assessment.

Blood Tests and Brain Imaging

Blood tests

Blood tests are a standard part of every first cognitive assessment. Their primary purpose is to identify reversible causes of cognitive impairment — conditions that can mimic dementia but respond to treatment.

Routine tests include:

Thyroid function (TSH) — hypothyroidism causes slowed thinking and memory difficulties
Vitamin B12 and folate — deficiency is common in older adults and directly impairs cognition
Full blood count — anaemia reduces oxygen delivery to the brain
Kidney and liver function — both affect drug clearance and metabolic balance
Fasting blood glucose or HbA1c — diabetes and hypoglycaemia both affect cognition
Calcium — hypercalcaemia can cause confusion and cognitive slowing
Inflammatory markers (CRP, ESR) — elevated in infections or inflammatory conditions

Brain imaging

Not everyone with memory concerns needs a brain scan at the first assessment. Imaging is typically arranged when:

The cause is not clear from clinical assessment and blood tests
The presentation is atypical or unusually rapid
There are neurological signs (weakness, coordination problems, gait abnormality)
A structural cause needs to be excluded (tumour, subdural haematoma, hydrocephalus)
The assessment is conducted in a specialist or memory clinic setting

CT scan — widely available; good for excluding bleeds, tumours, large infarcts, and normal pressure hydrocephalus.

MRI scan — more detailed; can show hippocampal atrophy (associated with Alzheimer’s), white matter changes (vascular disease), and subtle cortical changes. The preferred imaging modality in specialist dementia assessment.

Advanced biomarker testing

In specialist settings — particularly memory clinics and research centres — additional tests may be used to identify underlying Alzheimer’s disease pathology:

Amyloid PET scan — detects amyloid plaque burden in the brain; confirms Alzheimer’s pathology with high accuracy
CSF biomarkers — analysis of cerebrospinal fluid (obtained by lumbar puncture) for amyloid-beta, total tau, and phospho-tau
Blood-based biomarkers — plasma p-tau217 and amyloid ratio tests are increasingly used to support or exclude Alzheimer’s pathology with a simple blood test

These are not yet standard in routine GP assessment, but are becoming more relevant as disease-modifying treatments become available and treatment eligibility decisions require confirmed pathology.

What Results Can and Cannot Tell You

What a cognitive assessment can establish

Whether there is measurable decline from age-expected norms on standardised testing
Which cognitive domains are most affected — memory, attention, executive function, language
Whether the pattern is consistent with a particular type of dementia or another cause
Whether a reversible cause (depression, thyroid disease, B12 deficiency, medication effect) is likely contributing
Whether further specialist investigation is warranted

What it cannot tell you

A screening assessment alone cannot diagnose dementia — a clinical diagnosis requires the full picture over time
It cannot reliably predict whether MCI will progress to dementia, or when
A single normal result does not mean concerns should be dismissed
Results always need to be interpreted in the context of the individual: their age, education, baseline ability, mood, health, and the history of their symptoms

The importance of monitoring

In many cases — particularly early or mild presentations — the most informative step is not a single test result but a pattern over time. Repeat assessment at 6 or 12 months can clarify whether cognition is stable, slowly declining, or improving. This serial monitoring is standard practice in memory clinics and for people with an MCI diagnosis.

Specialist Memory Clinics and Neuropsychology

When referral to a memory clinic is appropriate

A GP will typically refer to a memory clinic when:

Initial assessment suggests moderate or progressive cognitive impairment
The cause is unclear or complex
Specialist investigation (imaging, biomarkers) is needed
A formal diagnosis is required for legal, practical, or treatment access reasons
The presentation is atypical — for example, young onset (under 65), rapid progression, or prominent behavioural change

What a memory clinic appointment involves

A memory clinic assessment is usually more detailed than a GP assessment. It typically includes:

Specialist medical assessment by a neurologist, geriatrician, or old age psychiatrist
Detailed cognitive testing (ACE-III or equivalent)
Brain imaging (usually MRI) if not already performed
Extended blood panel
Discussion of diagnosis, prognosis, and management with the person and their family
Access to support services — social work, occupational therapy, carer support

Neuropsychological assessment

For complex or ambiguous cases, referral to a neuropsychologist provides the most detailed cognitive profiling available. Neuropsychological testing uses a battery of standardised tasks to map performance across every major cognitive domain with high precision. It takes 2–4 hours and produces a detailed profile that can:

Distinguish between different patterns of impairment (amnestic vs. executive vs. language-predominant)
Separate genuine cognitive decline from the effects of anxiety, depression, or low educational background
Establish a detailed baseline for monitoring change over time
Clarify whether difficulties are likely functional (related to mood or stress) or structural

What to Do Before and After an Assessment

Before the appointment

Bring a family member or close contact — someone who knows the person well and can describe what they have observed. This is one of the most valuable contributions to the assessment.
Bring a medication list — including all prescription drugs, over-the-counter medications, and supplements.
Write down your concerns in advance — what has changed, when it started, specific examples. It is easy to forget in the moment what prompted the appointment.
Check practical logistics — whether the person wears hearing aids or glasses (bring them), and whether they have eaten normally beforehand.
Do not coach or prepare the person with answers to likely test questions — a natural, uncoached performance gives the clinician the most useful information.

After the assessment

Ask for a clear summary — what was found, what the likely explanation is, and what the next steps are.
Ask about monitoring — if no clear diagnosis was made, when should things be reviewed?
Discuss driving — if the clinician raises concerns about driving, take this seriously. Driving assessment referral is a clinical recommendation, not a punishment.
Access support early — if a diagnosis of MCI or dementia is made or considered likely, connecting with support organisations and planning for the future while capacity is retained is strongly encouraged.
Follow up on blood results and imaging — if tests were ordered at the appointment, ensure results are received and discussed.

When to Seek Urgent Medical Care Instead

Cognitive assessment through a GP or memory clinic is appropriate for gradually developing or stable memory and thinking concerns. It is not the right pathway for:

Call emergency services immediately if there is:

Sudden confusion or rapid-onset disorientation (possible delirium, stroke, or another acute cause)
Face drooping, arm weakness, or speech difficulty — possible stroke
Sudden severe headache
Seizure
Loss of consciousness or unresponsiveness
High fever with confusion

Seek same-day urgent care if:

Confusion has developed over hours to days — this is delirium until proven otherwise
There has been a sudden, definite worsening in someone with known dementia
Confusion is accompanied by signs of infection (fever, dysuria, productive cough)

A memory clinic appointment booked weeks ahead is not appropriate for sudden change. See: Delirium vs Dementia: How to Tell the Difference · Recognising Stroke

FAQ

Q: What happens at a memory assessment appointment?
A: A first assessment typically covers what has changed and when, input from a family member if available, a 10–20 minute cognitive test, a medication and mood review, blood tests, and discussion of next steps. It is a structured clinical conversation — not an exam to pass or fail.

Q: Does a normal cognitive test result mean nothing is wrong?
A: Not necessarily. Screening tests can miss subtle early changes, particularly in people with high baseline ability or education. If concerns are genuine and worsening, a normal result should prompt monitoring or referral — not simply dismissal.

Q: What is the MoCA test?
A: The Montreal Cognitive Assessment (MoCA) is a 30-point screening tool covering memory, attention, executive function, language, visuospatial ability, abstraction, and orientation. It takes 10–15 minutes and is more sensitive to early cognitive impairment than the older MMSE. A score of 26 or above is generally considered normal, with education adjustment available.

Q: Can anxiety or depression affect cognitive test results?
A: Yes, significantly. Depression can produce cognitive slowing and memory complaints that closely mimic dementia. Anxiety impairs working memory and attention. This is why mood is always assessed — treating depression or anxiety can substantially or completely reverse cognitive symptoms.

Q: What is a memory clinic?
A: A specialist outpatient service — led by a neurologist, geriatrician, or old age psychiatrist — providing more detailed assessment for suspected dementia or complex cognitive problems. Memory clinics offer extended cognitive testing, brain imaging, specialist examination, and access to support services beyond what is available in primary care.

Q: Are cognitive tests accurate?
A: They are useful but imperfect clinical tools. They can miss early or subtle impairment in high-functioning individuals (false negatives) and can flag borderline results in people who are simply anxious or tired (false positives). Results are always interpreted alongside the full clinical picture — not in isolation.

Q: What if someone refuses to be assessed?
A: This is understandable — the prospect of a diagnosis is frightening. A GP appointment framed around general health, fatigue, or sleep is often a less confronting starting point. If there are safety concerns, a family member can raise these with the GP separately.